Johnson & Johnson Innovative Medicine Valid
CEP Certificates (EDQM COS List)
Johnson & Johnson Innovative Medicine Valid
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 23
- Latest End Date -
- Data Source EDQM
- Last Updated 2025-05-30
Company Overview
Social Profiles
Company Snapshot
Johnson & Johnson Innovative Medicine Valid
1125 Trenton-Harbourton Road, P.O. Box 200, Titusville, NJ 08560
U.S.A
www.janssen.com/us/ View on MapCEP Records Timeline (23 records)
Product
Methylphenidate hydrochloride, Process II
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
CEP 2024-590 - Rev 00
Substance No.
2235
Issue Date
2025-05-30
End Date
-
Country
Belgium
Identifiers
Certificate No.: CEP 2024-590 - Rev 00
Substance No.: 2235
Product
Methylphenidate hydrochloride
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
CEP 2009-219 - Rev 04
Substance No.
2235
Issue Date
2024-12-23
End Date
-
Country
Belgium
Identifiers
Certificate No.: CEP 2009-219 - Rev 04
Substance No.: 2235
Product
Flunarizine dihydrochloride
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2005-097 - Rev 04
Substance No.
1722
Issue Date
2023-07-31
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2005-097 - Rev 04
Substance No.: 1722
Product
Miconazole nitrate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R2-CEP 1995-008 - Rev 04
Substance No.
513
Issue Date
2023-03-01
End Date
-
Country
Belgium
Identifiers
Certificate No.: R2-CEP 1995-008 - Rev 04
Substance No.: 513
Product
Domperidone maleate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1996-084 - Rev 03
Substance No.
1008
Issue Date
2022-09-05
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1996-084 - Rev 03
Substance No.: 1008
Product
Sufentanil citrate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1998-116 - Rev 07
Substance No.
1269
Issue Date
2022-07-07
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1998-116 - Rev 07
Substance No.: 1269
Product
Galantamine hydrobromide, Produced by a synthetic process
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2012-248 - Rev 01
Substance No.
2366
Issue Date
2021-11-19
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2012-248 - Rev 01
Substance No.: 2366
Product
Ketoconazole
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R2-CEP 1995-009 - Rev 04
Substance No.
921
Issue Date
2021-03-08
End Date
-
Country
Belgium
Identifiers
Certificate No.: R2-CEP 1995-009 - Rev 04
Substance No.: 921
Product
Levocabastine hydrochloride
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2002-147 - Rev 03
Substance No.
1484
Issue Date
2020-12-09
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2002-147 - Rev 03
Substance No.: 1484
Product
Econazole nitrate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2006-126 - Rev 03
Substance No.
665
Issue Date
2020-09-03
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2006-126 - Rev 03
Substance No.: 665
Product
Loperamide hydrochloride
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R2-CEP 1994-020 - Rev 05
Substance No.
929
Issue Date
2019-11-19
End Date
-
Country
Belgium
Identifiers
Certificate No.: R2-CEP 1994-020 - Rev 05
Substance No.: 929
Product
Domperidone
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1996-069 - Rev 10
Substance No.
1009
Issue Date
2019-10-22
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1996-069 - Rev 10
Substance No.: 1009
Product
Fentanyl citrate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1998-045 - Rev 06
Substance No.
1103
Issue Date
2019-06-17
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1998-045 - Rev 06
Substance No.: 1103
Product
Fentanyl
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1998-044 - Rev 03
Substance No.
1210
Issue Date
2018-01-18
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1998-044 - Rev 03
Substance No.: 1210
Product
Itraconazole, Method 1
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1999-092 - Rev 07
Substance No.
1335
Issue Date
2017-02-07
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1999-092 - Rev 07
Substance No.: 1335
Product
Risperidone
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2001-183 - Rev 05
Substance No.
1559
Issue Date
2017-01-10
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2001-183 - Rev 05
Substance No.: 1559
Product
Alfentanil hydrochloride hydrate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1997-086 - Rev 03
Substance No.
1062
Issue Date
2016-09-23
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1997-086 - Rev 03
Substance No.: 1062
Product
Itraconazole, Method 2 (alternative synthesis)
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2001-140 - Rev 05
Substance No.
1335
Issue Date
2016-01-22
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2001-140 - Rev 05
Substance No.: 1335
Product
Miconazole
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R2-CEP 1995-007 - Rev 03
Substance No.
935
Issue Date
2014-11-14
End Date
-
Country
Belgium
Identifiers
Certificate No.: R2-CEP 1995-007 - Rev 03
Substance No.: 935
Product
Haloperidol decanoate
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2002-187 - Rev 04
Substance No.
1431
Issue Date
2014-06-12
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2002-187 - Rev 04
Substance No.: 1431
Product
Haloperidol
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 1998-076 - Rev 09
Substance No.
616
Issue Date
2014-06-05
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 1998-076 - Rev 09
Substance No.: 616
Product
Cinnarizine
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R2-CEP 1994-016 - Rev 03
Substance No.
816
Issue Date
2011-10-27
End Date
-
Country
Belgium
Identifiers
Certificate No.: R2-CEP 1994-016 - Rev 03
Substance No.: 816
Product
Flubendazole
Substance
JANSSEN PHARMACEUTICA NV Beerse BE
Certificate No.
R1-CEP 2003-202 - Rev 00
Substance No.
1721
Issue Date
2010-01-12
End Date
-
Country
Belgium
Identifiers
Certificate No.: R1-CEP 2003-202 - Rev 00
Substance No.: 1721
Status Breakdown
23 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
Belgium
Identifiers
Certificate No.: CEP 2024-590 - Rev 00
Substance No.: 2235
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.